Arrowhead Pharmaceuticals, Inc. today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-INHBE, the company's investigational RNA interference (RNAi) therapeutic ...
NONGPOH: A·doko skanggipa Ri Bhoi Park-ko ra·bana sianichi Ri Bhoi District namen kusi ong·na a·bachenganiko niknasienga. Ua park-na Mawtnum songo Meghalaya Industrial Development Corporation (MIDC) ...
But is the same true for local government? A new survey, conducted by the nonprofit organization CivicPulse and commissioned by Carnegie, reveals a different story In partnership with the American ...